البريد الإلكتروني: bd@sidmexinovia.com
رقم الهاتف: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
الرئيسية >
Tysabri 300 mg Injection
Tysabri 300 mg Injection
Manufacturer/Marketed By : Biogen Idec Biotech India Pvt Ltd
$1068.52 $957.62
Tysabri 300 mg injection is a targeted monoclonal antibody designed to manage multiple sclerosis, a chronic condition affecting the central nervous system, as well as Crohn's disease, a type of...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Natalizumab 300 mg
Active Pharmaceutical Ingredient
Tysabri 300 mg Injection
1,068.52 US$
957.62 US$
Tysabri 300 mg injection is a targeted monoclonal antibody designed to manage multiple sclerosis, a chronic condition affecting the central nervous system, as well as Crohn's disease, a type of inflammatory bowel disorder, primarily in adults. This medication works by modulating the immune system, specifically inhibiting the action of certain immune cells that can cause harm to healthy tissue, thereby reducing inflammation and potentially preserving nerve function. While Tysabri can be effective in alleviating symptoms and improving the quality of life for patients with these conditions, it is crucial to note that its safety and effectiveness have not been evaluated in individuals under 18 years of age. Patients should also be aware of potential risks associated with the treatment, including the possibility of serious infections and other complications. As such, regular monitoring by healthcare professionals is essential during the course of therapy. By choosing Tysabri, patients may find a new avenue for managing their symptoms and enhancing their overall well-being. Always consult your healthcare provider for personalized advice and to ensure this treatment is appropriate for your specific condition.
Active Pharmaceutical Ingredient
الاستخدامات
• Tysabri 300 mg injection is utilized in the treatment of multiple sclerosis (MS), a neurological disorder that affects the central nervous system. This medication helps to reduce the frequency of relapses and slows the progression of disability in individuals diagnosed with MS. By targeting specific immune responses, Tysabri 300 mg injection aids in protecting nerve fibers from damage. Patients often experience improvements in their overall quality of life as a result of this treatment.
• Another important application of Tysabri 300 mg injection is in the management of Crohn's disease, a chronic inflammatory bowel condition. This medication works by modulating the immune system to decrease inflammation in the digestive tract. Patients receiving Tysabri 300 mg injection may see a reduction in symptoms such as abdominal pain and diarrhea. As a result, this treatment can contribute to a more manageable disease course for those affected by Crohn's disease.
• Tysabri 300 mg injection is also indicated for patients who have not responded adequately to other treatments for their conditions. It provides an alternative therapeutic option for individuals dealing with the complexities of both MS and Crohn's disease. By offering a different mechanism of action, Tysabri 300 mg injection can help those who need additional support in managing their symptoms. This flexibility makes it a valuable choice in personalized patient care.
• The administration of Tysabri 300 mg injection is typically part of a comprehensive treatment plan overseen by healthcare professionals. It is often used in conjunction with other therapies to optimize outcomes for patients. Regular monitoring and assessment are essential to ensure that the treatment is effective and to adjust the approach as necessary. This collaborative strategy helps maximize the benefits of Tysabri 300 mg injection for patients with MS and Crohn's disease.
فوائد
Multiple sclerosis (MS) is a condition that affects the brain and spinal cord, characterized by the immune system mistakenly attacking the protective covering of nerves, known as myelin. This assault leads to a variety of symptoms including vision problems, pain, fatigue, and difficulties with coordination. Tysabri 300 mg Injection is designed to intervene by suppressing the immune system, thus slowing down the progression of the disease. Reducing inflammation around the damaged nerves helps halt further deterioration and stabilise the immune response. This medication also aids in enhancing muscle strength, thereby improving mobility and boosting patients' confidence, ultimately contributing to an improved quality of life.
Crohn's disease, on the other hand, is a type of inflammatory bowel disease (IBD) characterised by chronic inflammation anywhere along the digestive tract, from the mouth to the anus. In this condition, the immune system attacks the lining of the digestive tract, resulting in inflammation, ulceration, and thickening of the bowel wall. Tysabri 300 mg Injection functions by selectively binding to specific immune cells, preventing their migration across both the blood-brain barrier and the inflamed intestinal lining. This mechanism effectively reduces inflammation in the affected regions, offering relief from symptoms associated with Crohn's disease.
تأثيرات جانبية
As with any medication, Tysabri 300 mg Injection may elicit side effects, which typically resolve as your body acclimates to the treatment and do not necessitate immediate medical intervention. However, if these side effects persist or cause concern, it's advisable to seek guidance from your doctor for further evaluation and management.
الآثار الجانبية الأكثر شيوعًا
• Diarrhoea
• Vaginitis
• Rash
• Nose and throat infections
• Nausea


